Medicago Cultura de la Empresa

Dr. Bruce Clark joined Medicago as CEO in March 2017. Since 2013, Dr. Clark served as a member of Medicago's board of Directors where he acquired a deep understanding of the company thus ensuring continuity of the corporate strategy and objectives. He brings with him a broad experience in the management of commercial operations, regulatory and quality having brought new products to market on the international scene. He spent many years as the head of regulatory and scientific affairs in companies such as Apotex Canada, Sanofi Synthelabo Canada, GSK, Medexus inc. and most recently as Vice President of Regulatory and Scientific Affairs of Philip Morris International based in Switzerland. He has been extensively involved with both European and US Generic pharmaceutical associations on the issue of biosimilars and complex therapeutics and has represented the industry in dialogue with political decision-makers as well as regulatory authorities at both National and State levels. Co-author of the biosimilar handbook published by the EGA and co-author of the Canadian handbook on Second Entry Biologics published by the Canadian Generic Pharmaceutical Association. He completed his studies in molecular biology and biochemistry at the University of Toronto where he received his PhD in 1997.

Mike Wanner is Medicago's Chief Financial Officer and U.S. Site Manager, and is responsible for developing the financial strategies of the company and for corporate governance. He also serves as executive lead of the IT function and strategies. He was previously President and CEO of Abeome, a biotec

Nathalie Landry is a dynamic biotech leader with more than 25 years of experience leading teams and programs to successful milestones. At Medicago, she oversees a multidisciplinary team in charge of R&D, preclinical and clinical development, clinical immunology, as well as?scientific and medical aff

Dr. Michael Schunk has more than 20 years of experience in the vaccine industry. He was Vice President of Quality at Medicago before taking his current role. He led manufacturing at Sanofi Pasteur, where he was responsible for both viral and bacterial vaccine manufacturing operations in multiple fac

Jean-Luc Martre has over 30 years of commercial experience in the pharmaceutical industry in sales, marketing, customer service, business development, communications and government affairs. Before joining Medicago he acquired his experience in specialty pharma, OTC, nutraceuticals and vaccines wit

Lorrie Deyelle has been transforming the way human resource groups develop, build and measure business value for over 30 years. As Vice President of Human Resources at Medicago, Lorrie is the leader responsible for the identification, development, and implementation of global human resource strategi

Thomas H serves as the Senior Director, Global Commercial Development of Medicago. Thomas started at Medicago in February of 2016. Thomas currently resides in the Greater Chicago Area.

Michael Wanner serves as the CFO and Executive Vice President of Operations of Medicago. Michael started at Medicago in July of 2010. Michael currently resides in the Athens, Georgia Area.

Pat Schimke serves as the Vice President of Analytical Development and Quality Control of Medicago. Pat started at Medicago in June of 2017. Pat currently resides in the Greater Boston Area.